The University of Hong Kong: COVID-19 trials

The registry lists 19 COVID-19 studies with The University of Hong Kong as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 7No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection in the Emergency Department TrialNot yet recruitingNCT06780566Not applicable
• The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable DiseasesRecruitingNCT05248412
• Intradermal COVID-19 Vaccination in the ImmunocompromisedStatus unknownNCT05736913Phase 2
• Community-based Sero-epidemiological Study of COVID-19CompletedNCT05599555
• To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2Status unknownNCT05200741Phase 2
• Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic ResonanceCompletedNCT05184114Not applicable
• A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19Status unknownNCT05102643Phase 1
• Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR)CompletedNCT04864899Not applicable
• A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19Status unknownNCT04809389Phase 1
• Covid-19 Vaccination in Adolescents and ChildrenActive, not recruitingNCT04800133Phase 2
• Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong ResidentsStatus unknownNCT04668222Phase 1/2
• IFN-beta 1b and Remdesivir for COVID19Status unknownNCT04647695Phase 2
• IFN Beta-1b and Ribavirin for Covid-19Status unknownNCT04494399Phase 2
• Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19Status unknownNCT04465695Phase 2
• COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via "Quit to Win" Contest 2020CompletedNCT04399967Not applicable
• The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their FamiliesStatus unknownNCT04365348
• The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong KongStatus unknownNCT04360863
• Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) SurvivorsStatus unknownNCT04355884
• Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19Status unknownNCT04343794Not applicable